[1] Wong ND. Epidemiological studies of CHD and the evolution of preventive cardiology. Nat Rev Cardiol. 2014;11(5):276-289. doi:10.1038/nrcardio.2014.26
[2] Writing Group Members, Mozaffarian D, Benjamin EJ, et al. Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association. Circulation. 2016;133(4):447-454. doi:10.1161/CIR.0000000000000366
[3] Mehilli J, Presbitero P. Coronary artery disease and acute coronary syndrome in women. Heart. 2020;106(7):487-492. doi:10.1136/heartjnl-2019-315555
[4] Khera AV, Kathiresan S. Genetics of coronary artery disease: discovery, biology and clinical translation. Nat Rev Genet. 2017;18(6):331-344. doi:10.1038/nrg.2016.160
[5] Won HH, Natarajan P, Dobbyn A, et al. Disproportionate Contributions of Select Genomic Compartments and Cell Types to Genetic Risk for Coronary Artery Disease. PLoS Genet. 2015;11(10):e1005622. Published 2015 Oct 28. doi:10.1371/journal.pgen.1005622
[6] Lloyd-Jones DM, Nam BH, D'Agostino RB Sr, et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA. 2004;291(18):2204-2211. doi:10.1001/jama.291.18.2204
[7] Fioranelli M, Bottaccioli AG, Bottaccioli F, Bianchi M, Rovesti M, Roccia MG. Stress and Inflammation in Coronary Artery Disease: A Review Psychoneuroendocrineimmunology-Based. Front Immunol. 2018;9:2031. Published 2018 Sep 6. doi:10.3389/fimmu.2018.02031
[8] Yang YL, Wu CH, Hsu PF, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50(5):e13230. doi:10.1111/eci.13230
[9] Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006;86(2):515-581. doi:10.1152/physrev.00024.2005
[10] Li GM, Zhang CL, Rui RP, Sun B, Guo W. Bioinformatics analysis of common differential genes of coronary artery disease and ischemic cardiomyopathy. Eur Rev Med Pharmacol Sci. 2018;22(11):3553-3569. doi:10.26355/eurrev_201806_15182
[11] Liu M, Jiang S, Ma Y, Ma J, Hassan W, Shang J. Peripheral-blood gene expression profiling studies for coronary artery disease and its severity in Xinjiang population in China. Lipids Health Dis. 2018;17(1):154. Published 2018 Jul 18. doi:10.1186/s12944-018-0798-1
[12] Kanehisa M, Sato Y, Kawashima M, Furumichi M, Tanabe M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 2016;44(D1):D457-D462. doi:10.1093/nar/gkv1070
[13] Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 2017;45(D1):D362-D368. doi:10.1093/nar/gkw937
[14] Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453-457. doi:10.1038/nmeth.3337
[15] Wong MC, Zhang DX, Wang HH. Rapid emergence of atherosclerosis in Asia: a systematic review of coronary atherosclerotic heart disease epidemiology and implications for prevention and control strategies. Curr Opin Lipidol. 2015;26(4):257-269. doi:10.1097/MOL.0000000000000191
[16] Canto JG, Kiefe CI, Rogers WJ, et al. Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. JAMA. 2011;306(19):2120-2127. doi:10.1001/jama.2011.1654
[17] Ding N, Sang Y, Chen J, et al. Cigarette Smoking, Smoking Cessation, and Long-Term Risk of 3 Major Atherosclerotic Diseases. J Am Coll Cardiol. 2019;74(4):498-507. doi:10.1016/j.jacc.2019.05.049
[18] Mandviwala T, Khalid U, Deswal A. Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker?. Curr Atheroscler Rep. 2016;18(5):21. doi:10.1007/s11883-016-0575-4
[19] Khamis RY, Ammari T, Mikhail GW. Gender differences in coronary heart disease. Heart. 2016;102(14):1142-1149. doi:10.1136/heartjnl-2014-306463
[20]Zhang W, Song M, Qu J, Liu GH. Epigenetic Modifications in Cardiovascular Aging and Diseases. Circ Res. 2018;123(7):773-786. doi:10.1161/CIRCRESAHA.118.312497
[21] Xu S, Pelisek J, Jin ZG. Atherosclerosis Is an Epigenetic Disease. Trends Endocrinol Metab. 2018;29(11):739-742. doi:10.1016/j.tem.2018.04.007
[22] Gong R, Chen MH, Peng LS, Wei SL. Common genes in coronary artery disease from Europe, Asia and North America regardless of race and lifestyle. Eur Rev Med Pharmacol Sci. 2015;19(6):1092-1100.
[23] Lu J, Chatterjee M, Schmid H, Beck S, Gawaz M. CXCL14 as an emerging immune and inflammatory modulator. J Inflamm (Lond). 2016;13:1. Published 2016 Jan 5. doi:10.1186/s12950-015-0109-9
[24] Hara T, Tanegashima K. Pleiotropic functions of the CXC-type chemokine CXCL14 in mammals. J Biochem. 2012;151(5):469-476. doi:10.1093/jb/mvs030
[25]Shurin GV, Ferris RL, Tourkova IL, et al. Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo [published correction appears in J Immunol. 2006 Mar 15;176(6):3840. Ferris, Robert [corrected to Ferris, Robert L]]. J Immunol. 2005;174(9):5490-5498. doi:10.4049/jimmunol.174.9.5490
[26] Starnes T, Rasila KK, Robertson MJ, et al. The chemokine CXCL14 (BRAK) stimulates activated NK cell migration: implications for the downregulation of CXCL14 in malignancy. Exp Hematol. 2006;34(8):1101-1105. doi:10.1016/j.exphem.2006.05.015
[27] Tanegashima K, Suzuki K, Nakayama Y, et al. CXCL14 is a natural inhibitor of the CXCL12-CXCR4 signaling axis. FEBS Lett. 2013;587(12):1731-1735. doi:10.1016/j.febslet.2013.04.046
[28]Puca AA, Carrizzo A, Spinelli C, et al. Single systemic transfer of a human gene associated with exceptional longevity halts the progression of atherosclerosis and inflammation in ApoE knockout mice through a CXCR4-mediated mechanism. Eur Heart J. 2020;41(26):2487-2497. doi:10.1093/eurheartj/ehz459
[29] Witte A, Rohlfing AK, Dannenmann B, et al. The chemokine CXCL14 mediates platelet function and migration via direct interaction with CXCR4. Cardiovasc Res. 2021;117(3):903-917. doi:10.1093/cvr/cvaa080
[30]Battaglino R, Fu J, Späte U, et al. Serotonin regulates osteoclast differentiation through its transporter. J Bone Miner Res. 2004;19(9):1420-1431. doi:10.1359/JBMR.040606
[31] Gao W, Liu H, Yuan J, et al. Exosomes derived from mature dendritic cells increase endothelial inflammation and atherosclerosis via membrane TNF-α mediated NF-κB pathway. J Cell Mol Med. 2016;20(12):2318-2327. doi:10.1111/jcmm.12923
[32] Niu YC, Feng RN, Hou Y, et al. Histidine and arginine are associated with inflammation and oxidative stress in obese women. Br J Nutr. 2012;108(1):57-61. doi:10.1017/S0007114511005289
[33] Neuhofer A, Wernly B, Leitner L, et al. An accelerated mouse model for atherosclerosis and adipose tissue inflammation. Cardiovasc Diabetol. 2014;13:23. Published 2014 Jan 17. doi:10.1186/1475-2840-13-23
[34] Barrett TJ. Macrophages in Atherosclerosis Regression. Arterioscler Thromb Vasc Biol. 2020;40(1):20-33. doi:10.1161/ATVBAHA.119.312802
[35] Eligini S, Cosentino N, Fiorelli S, et al. Biological profile of monocyte-derived macrophages in coronary heart disease patients: implications for plaque morphology. Sci Rep. 2019;9(1):8680. Published 2019 Jun 18. doi:10.1038/s41598-019-44847-3
[36] Olson NC, Doyle MF, Jenny NS, et al. Decreased naive and increased memory CD4(+) T cells are associated with subclinical atherosclerosis: the multi-ethnic study of atherosclerosis. PLoS One. 2013;8(8):e71498. Published 2013 Aug 23. doi:10.1371/journal.pone.0071498
[37] Ammirati E, Cianflone D, Vecchio V, et al. Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal Models. J Am Heart Assoc. 2012;1(1):27-41. doi:10.1161/JAHA.111.000125